Tamoxifen Citrate: Research Overview

December 5, 2019

Clinical research is significant and should be considered a priority in the health sector as its findings to introduce safe and effective medicine into the health system.

With further clinical evaluation, the most effective and safest medicine are discovered and authorized for healthy administration.

What is Tamoxifen Citrate?

The product was initially produced by chemist Dora Richardson in 1962. Tamoxifen also is known as Tamoxifen Citrate, or just TMX

Chemical and Physical Data of Tamoxifen

Tamoxifen is a nonsteroidal antiestrogen medication widely used in the treatment of breast cancer. Its chemical name is (Z)-2-[4-(1,2-diphenylbut-1-enyl)phenyl]-5-methyl-1,3-benzothiazol-3-ium, and it has a molecular formula of C26H29NO with a molecular weight of 371.51 g/mol. This compound appears as a white or off-white crystalline powder, which is soluble in ethanol and methanol. Tamoxifen is available in both tablet and oral solution forms, making it versatile for different treatment protocols.

Chemical and physical data Tamoxifen

Molecular formula: C2629NO

Molecular mass: 371.515 g/mol

563.638 g/mol (citrate salt) g.mol-1

Identifier

CAS number: 10540-29-1

Uses of Tamoxifen

Early Breast Cancer

Male Breast Cancer

Since its approval in 1998, the compound has been used for Albright Syndrome to treat premature puberty. It is popularly called McCune-Albright Syndrome (MAS). MAS is a disorder that affects the skin, bones, and endocrine or hormones-producing tissues.

Animal studies/research

Besides cancer and MAS treatments, Tamoxifen can be used for animal studies. It is administered into animals, the test subjects, as a research instrument to initiate tissue-specific gene expression in many conditional expression constructs of genetically modified animals.

Such administration into animals should be appropriately carried out in an LASC chemical housing room considering ABSL-2 type PPE (Personal Protective Equipment).

Administration of Tamoxifen in test subject (animals) can either be acute or chronic.

After successful administration, it is advisable for the test subject to be kept indoors in ABSL-2 for about three days.

Effects of Tamoxifen in Breast Cancer Prevention

Tamoxifen is one of the most used selective estrogen receptor modulator (SERM) or a partial agonist of the estrogen receptors (ER) and, it’s widely recommended for breast cancer and McCune-Albright Syndrome.

Tamoxifen helps to:

• Funk large hormone-receptor-positive before surgery

However, it will be a futile effort to use Tamoxifen for hormone-receptor-negative breast cancer as it only has used for hormone-receptor-positive breast cancer.

• Prevent osteoporosis

• Infertility treatment

Comprehensive Overview of Tamoxifen Uses in Metastatic Breast Cancer Treatment

The mechanism of action Tamoxifen or Tamoxifen/TMX is complex. It has been successful in rats.

The breast cancer index is a crucial tool in risk prediction programs that identify women at high risk of developing breast cancer. By considering factors such as mammographic density and genetic markers, these indices help tailor prevention strategies and screening approaches for breast cancer.

Tamoxifen in Breast Cancer Treatment

Tamoxifen is a cornerstone in the treatment of breast cancer for both men and women.

Tamoxifen for Breast Cancer Prevention

Tamoxifen plays a pivotal role in breast cancer prevention, particularly for women at high risk. Additionally, for women who have already been diagnosed with breast cancer, Tamoxifen helps lower the risk of developing contralateral breast cancer.

How Tamoxifen Works

Tamoxifen is metabolized by the liver and excreted in the urine, ensuring that it is processed and eliminated efficiently from the body.

Where to buy Tamoxifen

Tamoxifen can be purchased in research form from Loti Labs. Tamoxifen generally is sold in liquid form in a concentration of 20mg per ml. Be sure that when purchasing tamoxifen you do so from a reputable online vendor that uses 3rd party testing on their products.

Reference

1. Tamoxifen Citrate. NCI. August 26, 2015. Archived from the original on  4 January 2016.Retrieved 28 November 2015.

2. Selective estrogen receptor modulators. Archived from the original on the 9 December 2013. I have retrieved 28 November 2015.

3. Jordan VC (January 2006). Tamoxifen (ICI46,474) as a therapy which was produced to treat and prevent breast cancer. British Journal of Pharmacology. 147 Suppl 1 (Suppl 1): S269-76.

Future Directions in Tamoxifen Research

Additionally, there is significant interest in using Tamoxifen for breast cancer prevention in high-risk women.

By following this structured approach, the new sections will provide a comprehensive and detailed overview of Tamoxifen, maintaining the informative and technical tone of the existing article.